# Effects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated Patients

> **NCT07065942** · NA · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus
- Constipation - Functional

## Interventions

- **DRUG:** Lactulose oral solution
- **DRUG:** Live Combined B. Subtilis and E. Faecium Enteric-coated Capsules

## Key facts

- **NCT ID:** NCT07065942
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07065942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07065942, "Effects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated Patients". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07065942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*